Evidence map›Paper›PMID 29579099›Full record

Trial reportPloS one2018

Severe influenza A(H1N1)pdm09 in pregnant women and neonatal outcomes, State of Sao Paulo, Brazil, 2009.

Ana Freitas Ribeiro, Alessandra Cristina Guedes Pellini, Beatriz Yuko Kitagawa, Daniel Marques, Geraldine Madalosso, Joao Fred, Ricardo Kerti Mangabeira Albernaz, Telma Regina Marques Pinto Carvalhanas, Dirce Maria Trevisan Zanetta

Abstract readClinical Trial
In one paragraph

Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ana Freitas RibeiroEpidemiological Surveillance Center, Sao Paulo State Secretary of Health, São Paulo, São Paulo, Brazil.ORCID 0000-0001-9111-4510
Alessandra Cristina Guedes PelliniEpidemiological Surveillance Center, Sao Paulo State Secretary of Health, São Paulo, São Paulo, Brazil.
Beatriz Yuko KitagawaEpidemiological Surveillance Center, Sao Paulo State Secretary of Health, São Paulo, São Paulo, Brazil.
Daniel MarquesEpidemiological Surveillance Center, Sao Paulo State Secretary of Health, São Paulo, São Paulo, Brazil.
Geraldine MadalossoEpidemiological Surveillance Center, Sao Paulo State Secretary of Health, São Paulo, São Paulo, Brazil.
Joao FredEpidemiological Surveillance Center, Sao Paulo State Secretary of Health, São Paulo, São Paulo, Brazil.
Ricardo Kerti Mangabeira AlbernazEpidemiological Surveillance Center, Sao Paulo State Secretary of Health, São Paulo, São Paulo, Brazil.
Telma Regina Marques Pinto CarvalhanasEpidemiological Surveillance Center, Sao Paulo State Secretary of Health, São Paulo, São Paulo, Brazil.
Dirce Maria Trevisan ZanettaDepartment of Epidemiology, School of Public Health - University of Sao Paulo, São Paulo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the factors associated with death and describe the gestational outcomes in pregnant women with influenza A(H1N1)pdm09, we conducted a case-control study (deaths and recovered) in hospitalized pregnant women with laboratory-confirmed influenza A(H1N1)pdm09 with severe acute respiratory illness (SARI) in the state of São Paulo from June 9 to December 1, 2009. All cases were evaluated, and four controls that were matched by the epidemiological week of hospitalization of the case were randomly selected for each case. Cases and controls were selected from the National Disease Notification System-SINAN Influenza-web. The hospital records from 126 hospitals were evaluated, and home interviews were conducted using standardized forms. A total of 48 cases and 185 controls were investigated. Having had a previous health visit to a healthcare provider for an influenza episode before hospital admission was a risk factor for death (adjusted OR (ORadj) of 7.93, 95% CI 2.19-28.69). Although not significant in the multiple analysis (ORadj of 2.13, 95% CI 0.91-5.00), the 3rd trimester deserves attention, with an OR = 2.22, 95% CI 1.13-4.37 in the univariate analysis. Antiviral treatment was a protective factor when administered within 48 hours of symptom onset (ORadj = 0.16, 95% CI 0.05-0.50) and from 48 to 72 hours (ORadj = 0.09, 95% CI 0.01-0.87). There was a higher proportion of fetal deaths and preterm births among cases (p = 0.001) and live births with low weight (p = 0.019), compared to control subjects who gave birth during hospitalization. After discharge, control subjects had a favorable neonatal outcome. Early antiviral treatment during the presence of a flu-like illness is an important factor in reducing mortality from influenza in pregnant women and unfavorable neonatal outcomes. It is important to monitor pregnant women, particularly in the 3rd trimester of gestation, with influenza illness for diagnosis and early treatment.

Indexed as

Fetal DeathHospitalizationInfluenza A Virus, H1N1 SubtypeInfluenza, HumanPregnancy Complications, InfectiousAdolescentAdultBrazilFemaleHumansInfant, NewbornMiddle AgedPregnancyPregnancy Trimester, ThirdPremature BirthRisk Factors

Identifiers

PMID29579099
PMCPMC5868799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.